Tüdőrák: vizsgálatok itt: Japán
132 of 135 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Kanagawa, Kyoto, Tokyo
- Életkor
- 18 év and over
- People
- 623 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Hidaka, Kagoshima, Kanagawa, Kashiwa-shi, Matsuyama, Nagaizumi-chō, Nagoya, Osakasayama-Shi, Saitama, Tokyo, Yokohama
- Életkor
- 18 év and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 3. fázisTaking peoplePembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- Where
- Chiba, Fukuoka, Hirakata, Hirosaki, Kanazawa, Kashiwa, Kawasaki, Kitaadachi-gun, Kobe, Koto, Matsusaka, Nagoya, Nankoku, Niigata, Osaka, Ōta, Ōta-ku, Sendai, Shimotsuga-gun, Shinjuku, Takarazuka, Tōon, Toyoake, Ube, Ureshino, Yokohama
- Életkor
- 18 év and over
- People
- 851 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06422143 · EU 2023-510128-66-00 - 3. fázisTaking peopleA Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Where
- Chiba, Chūō, Fukuoka, Fukushima, Hirakata, Hiroshima, Kashiwa, Kawasaki, Kitakyushu, Okayama, Osaka, Sakai, Shimotsuga-gun, Shinjuku, Sunto-gun, Wakayama, Yokohama
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06623422 · EU 2023-506327-29-00 - 3. fázisTaking peopleA Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- Where
- Aomori, Bunkyo Ku, Fukuoka, Hamamatsu, Hidaka, Hirakata, Nagasaki, Nagoya, Osaka, Sagamihara, Sapporo, Sendai, Toyoma
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- Mirati Therapeutics Inc.
See details and how to joinNCT06875310 · EU 2024-515698-85-00 - 3. fázisTaking peopleLUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Where
- Bunkyo, Chuo Ku, Hidaka, Osaka, Sakai
- Életkor
- 18 év and over
- People
- 734 worldwide
- Run by
- NovoCure GmbH
See details and how to joinNCT06216301 - 3. fázisTaking peopleMK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
- Where
- Fukushima, Hirakata, Hirosaki, Kitakyushu, Osaka, Yamagata, Yufu
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07431827 · EU 2024-517337-41-00 - 3. fázisTaking peopleA Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Where
- Fukuoka, Fukushima, Kitakyushu, Yamagata
- Életkor
- 18 év and over
- People
- 876 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07513376 · EU 2025-522643-18-00 - 1/2. fázisTaking peopleA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- Where
- Chuo Ku, Koto-ku
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07730021 · EU 2026-525938-31-00 - 1. fázisFut, nem toborozA Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 453 worldwide
- Run by
- Pfizer
See details and how to joinNCT03460977 · EU 2023-509179-18-00 - 3. fázisTaking peopleA Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Where
- Bunkyo-ku, Chiba, Fukuoka, Fukuyama-shi, Hirakata-shi, Hirosaki-shi, Kanazawa, Kashiwa-shi, Kawasaki-shi, Kitakyushu-shi, Kobe, Koto-ku, Kurume-shi, Kyoto, Matsuyama, Nagoya, Natori-shi, Niigata, Okayama, Osaka, Sakai-shi, Sakai-Shi, Sapporo, Sendai, Shimotsuga-gun, Sunto-gun, Takarazuka-shi, Toon-shi, Ube-shi, Wakayama, Yokohama, Yonago-shi
- Életkor
- 18 év to 100 év
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT05920356 · EU 2022-501863-41-00 - 2/3. fázisTaking peopleA Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Where
- Bunkyo-ku, Fukuoka, Hidaka, Himeji, Hirakata, Kashiwa, Kawasaki, Kobe, Matsusaka, Nagoya, Nankoku, Okayama, Osaka, Otashi, Sapporo, Sendai, Shimotsuga, Shiwa-gun Yahaba-cho, Ube, Yokohama
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07063745 · EU 2025-521511-40-00 - 1/2. fázisTaking peopleA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Where
- Chuo Ku, Kashiwa-shi, Koto-ku
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07488676 - 1. fázisTaking peopleBeamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Where
- Chiba, Kashiwa, Ehime, Matsuyama, Hiroshima, Hiroshima, Osaka, Osaka, Osaka, Sakai, Shizuoka, Hamamatsu, Tokyo, Chuo-ku
- Életkor
- 18 év and over
- People
- 554 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT04886804 · EU 2024-511246-39-00 - 1/2. fázisFut, nem toborozFirst in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Chuo Ku, Kashiwa, Matsuyama, Nagoya, Okayama, Osaka, Sakai, Sapporo, Sunto, Yokohama, Yonago
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Bayer
See details and how to joinNCT05099172 · EU 2023-503795-24-00 - 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Bunkyo, Chiba, Fukuoka, Hirakata, Hiroshima, Kanazawa, Kashiwa, Kawasaki, Kitaadachi-gun, Kumamoto, Kurume, Matsusaka, Matsuyam, Nagoya, Natori-shi, Niigata, Osaka, Ōta, Ōta-ku, Sapporo, Sendai, Shinjuku, Takatsuki, Toyoake
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 3. fázisTaking peopleThis is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Where
- Asahikawa, Bunkyo-ku, Chuo Ku, Fukuoka, Kobe, Koto, Kurume, Kyoto, Meguro-Ku, Okayama, Osaka, Otashi, Sakai, Sendai, Suita, Tōon, Tsu, Yamagata, Yokohama
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Pfizer
See details and how to joinNCT06758401 · EU 2024-517968-36-00 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Chuo Ku, Koto-ku, Nagoya, Sakai, Sunto
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 2/3. fázisNot yet taking people in JapánStudy of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Where
- Chuo-ku, Hamamatsu, Hirakata, Ina-machi, Kashiwa, Koto-ku, Kurashiki, Kurume, Nagaizumi-cho,Sunto-gun, Nagoya, Nishinomiya, Ōsaka-sayama, Sapporo, Sendai, Tōon, Yokohama
- Életkor
- 18 év and over
- People
- 661 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07100080 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
- Where
- Bunkyo, Chiba, Fukuoka, Himeji, Hirakata, Hirosaki, Hiroshima, Kanazawa, Kawasaki, Kobe, Kumamoto, Kurume, Matsusaka, Nagoya, Osaka, Ōta, Ōta-ku, Sakai, Sendai, Shinjuku, Takarazuka, Takatsuki, Tōon, Toyoake, Ureshino, Yokohama
- Életkor
- 18 év and over
- People
- 675 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07190248 · EU 2024-514500-14-00 - 3. fázisTaking peopleA Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
- Where
- Kobe, Matsusaka, Ōta, Sapporo, Sendai, Shimotsugagun
- Életkor
- 18 év and over
- People
- 310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07554339 · EU 2025-522038-29-00 - 1/2. fázisNot yet taking people in JapánDAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Hokkaido, Sapporo, Kanagawa, Kawasaki, Osaka, Hirakata, Shizuoka, Sunto-gun
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00 - 4. fázisBefejeződöttDabrafenib and/or Trametinib Rollover Study
- Where
- Chuo Ku, Kashiwa
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisFut, nem toborozStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - 3. fázisTaking peopleA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Where
- Bunkyo-ku, Fukuoka, Fukushima, Hirakata, Hiroshima, Kashiwa, Kawasaki, Kitaadachi-gun, Kitakyushu, Kobe, Matsuyama, Nagasaki, Niigata, Okayama, Osaka, Sakai, Shinjuku, Tokyo, Yamagata, Yokohama
- Életkor
- 18 év and over
- People
- 780 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06312137 · EU 2023-508012-35-00